It would make sense if they were working with Sinopharm. Joe mentioned in the CC that members of China's CDC will be working on this. GNBT's vaccine would be beneficial for people who would be at risk, +60, from the adverse reactions from current vaccines. Today Pakistan said that it would not recommend Sinopharm's covid vaccine to 60+ individuals (Source: https://www.dawn.com/news/1605445/sinopharm-v...dr-faisal)

It would make sense especially now for Sinopharm to partner/work with GNBT to develop/bring to their covid vaccine to market.